Psoriasis Drug

More on PSORIASIS ...
What Causes Psoriasis?
Psoriasis is a skin disorder driven by the immune system, especially involving a type of white blood cell called a T cell. Normally, T cells help protect the body against infection and disease. In the case of psoriasis, T cells are put into action by mistake and become so active that they trigger other immune responses, which lead to inflammation and to rapid turnover of skin cells. In about one-third of the cases, there is a family history of psoriasis. Researchers have studied a large number of families affected by psoriasis and identified genes linked to the disease. (Genes govern every bodily function and determine the inherited traits passed from parent to child.)

People with psoriasis may notice that there are times when their skin worsens, then improves. Conditions that may cause flareups include infections, stress, and changes in climate that dry the skin. Also, certain medicines, including lithium and betablockers, which are prescribed for high blood pressure, may trigger an outbreak or worsen the disease. - NIAMS

Top Resource Searches For:

Psoriasis Drug

Dave's Psoriasis Info - Drug InfoNet
Dave's Prosiasis Info - Review of Drug InfoNet ... when looking for detailed information about psoriasis, Drug InfoNet should probably be avoided in ... of the National Psoriasis Foundation (about which Drug InfoNet is silent). When ...

CBS News | FDA OKs Psoriasis Drug | January 31, 2003 13:08:11
FDA OKs Psoriasis Drug. WASHINGTON, Jan. 31, 2003. (Photo: CBS/AP) Psoriasis is thought to form when the immune system runs amok and cells called memory effector T cells prompt skin inflammation. ... cells to control hard-to-treat psoriasis won Food and Drug Administration approval Friday, offering a long-awaited ...

Psoriasis Drug Approved
Breaking news on health topics for your family, finances, lifestyle, and business provided by applesforhealth.com, a healthy knowledge source. ... Eye DoctorsAlternate Health Prof.Drug InteractionsMedicationsDiseasesPoisonsInjuriesMental ... Psoriasis Drug Approved. The Food and Drug Administration has approved alefacept (Amevive ...

MedlinePlus: Psoriasis
... Targretin Shows Promise Against Psoriasis (08/26/2004, Reuters ... National Psoriasis Foundation Speakers in Support of New Psoriasis Drug (07/12/2004, National Psoriasis Foundation ...

Psoriasis Hall of PShame
A critical review of some deceptive psoriasis treatments promoted on the net. ... Psoriasis Hall of PShame ... an OTC drug. This allows the company to legally make various safety and efficacy claims for treating psoriasis, and they ...

Biogen psoriasis drug rejected in Europe
... Biogen psoriasis drug rejected in Europe. Biogen psoriasis drug rejected in Europe ...

HealthScout--New Psoriasis Drug Gains Approval
... Send to a Friend. New Psoriasis Drug Gains Approval ... A new drug to combat psoriasis has won approval from the U.S. Food and Drug Administration. ...

Psoriasis
The National Psoriasis Foundation (NPF) site provides much useful information on the nature of psoriasis and the various forms of treatment available. ... Psoriasis. Psoriasis; Psoriasis / drug therapy; Psoriasis / genetics; Psoriasis / prevention & control; Psoriasis ...

FDA Approves Psoriasis Drug Raptiva
Raptiva, from Genentech and Xoma, will compete with drugs from Amgen and Biogen. ... FDA Approves Psoriasis Drug Raptiva. By TSC Staff ... The Food and Drug Administration approved Monday a new psoriasis drug from biotech firms Genentech (DNA:NYSE ...

MSNBC - FDA approves new psoriasis drug
... FDA approves new psoriasis drug. Raptiva should be available to consumers by Thanksgiving ... the itchy-skin condition psoriasis won the Food and Drug Administration's approval Monday ...

National Psoriasis Foundation to Testify for Raptiva Approval
Password. News and Events. News. Federal Advisory Committee Recommends Approval of New Psoriasis Drug. Final approval could come by end of October. First posted Sept. 10, 2003. Last updated Sept. 23, 2003. In a unanimous vote on Sept. ... and Drug Administration (FDA) recommended approval of the psoriasis drug efalizumab (brand name Raptiva) for ...

Chronic Pain | Psoriasis Drug